{"entity":{"type":"insider","cik":"0001263499","url":"/insider/0001263499","json_url":"/insider/0001263499.json","name":"DUGAN RICHARD W","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":6,"first":"2004-10-25","last":"2022-06-02","span_basis":"filed_date"},"name_variants":[{"name":"DUGAN RICHARD W","source":"filing","n_filings":6,"first_seen":"2004-10-25","last_seen":"2022-06-02"}],"transactions":[{"id":6752584,"accession":"0001209191-22-033561","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-033561","line_url":"/filing/0001209191-22-033561#line-2","is_derivative":false,"issuer_cik":"0001263499","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001263499","owner_cik":"0001263499","owner_name":"DUGAN RICHARD W","owner_display_name":"DUGAN RICHARD W","owner_url":"/insider/0001263499","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":9.8542,"price_display":"9.85","price_state":"stated","total_value":64052.3,"total_display":"64,052.30","total_whole":"64,052","shares_owned_after":68387.0,"shares_owned_after_display":"68,387","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-31","filed_date":"2022-06-02","scope":"insider"},{"id":4223221,"accession":"0001209191-21-012204","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-012204","line_url":"/filing/0001209191-21-012204#line-2","is_derivative":false,"issuer_cik":"0001263499","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001263499","owner_cik":"0001263499","owner_name":"DUGAN RICHARD W","owner_display_name":"DUGAN RICHARD W","owner_url":"/insider/0001263499","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5754.0,"shares_display":"5,754","price_per_share":18.5372,"price_display":"18.54","price_state":"stated","total_value":106663.0488,"total_display":"106,663.05","total_whole":"106,663","shares_owned_after":54887.0,"shares_owned_after_display":"54,887","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"},{"id":3114382,"accession":"0001209191-20-032896","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-032896","line_url":"/filing/0001209191-20-032896#line-2","is_derivative":false,"issuer_cik":"0001263499","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001263499","owner_cik":"0001263499","owner_name":"DUGAN RICHARD W","owner_display_name":"DUGAN RICHARD W","owner_url":"/insider/0001263499","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10129.0,"shares_display":"10,129","price_per_share":11.0382,"price_display":"11.04","price_state":"stated","total_value":111805.9278,"total_display":"111,805.93","total_whole":"111,806","shares_owned_after":40641.0,"shares_owned_after_display":"40,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-28","filed_date":"2020-05-29","scope":"insider"},{"id":8102082,"accession":"0001209191-19-047610","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-047610","line_url":"/filing/0001209191-19-047610#line-2","is_derivative":false,"issuer_cik":"0001263499","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001263499","owner_cik":"0001263499","owner_name":"DUGAN RICHARD W","owner_display_name":"DUGAN RICHARD W","owner_url":"/insider/0001263499","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":14.85,"price_display":"14.85","price_state":"stated","total_value":222750.0,"total_display":"222,750.00","total_whole":"222,750","shares_owned_after":35770.0,"shares_owned_after_display":"35,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-26","filed_date":"2019-08-28","scope":"insider"},{"id":8882294,"accession":"0001209191-15-024608","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-024608","line_url":"/filing/0001209191-15-024608#line-2","is_derivative":false,"issuer_cik":"0001263499","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001263499","owner_cik":"0001263499","owner_name":"DUGAN RICHARD W","owner_display_name":"DUGAN RICHARD W","owner_url":"/insider/0001263499","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4804.0,"shares_display":"4,804","price_per_share":10.6859,"price_display":"10.69","price_state":"stated","total_value":51335.0636,"total_display":"51,335.06","total_whole":"51,335","shares_owned_after":5770.0,"shares_owned_after_display":"5,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-09","filed_date":"2015-03-10","scope":"insider"},{"id":256079,"accession":"0001209191-04-049410","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-04-049410","line_url":"/filing/0001209191-04-049410","is_derivative":false,"issuer_cik":"0001161924","issuer_name":"ADVANCIS PHARMACEUTICAL CORP","issuer_ticker":"AVNC","issuer_name_source":null,"issuer_url":"/issuer/0001161924","owner_cik":"0001263499","owner_name":"DUGAN RICHARD W","owner_display_name":"DUGAN RICHARD W","owner_url":"/insider/0001263499","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.87902,"price_display":"2.88","price_state":"stated","total_value":14395.1,"total_display":"14,395.10","total_whole":"14,395","shares_owned_after":3638.0,"shares_owned_after_display":"3,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-10-21","filed_date":"2004-10-25","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001347178","name":"Vanda Pharmaceuticals Inc.","url":"/issuer/0001347178","role":"Director","n_filings":5,"first_seen":"2015-03-10","last_seen":"2022-06-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001161924","name":"ADVANCIS PHARMACEUTICAL CORP","url":"/issuer/0001161924","role":"Director","n_filings":1,"first_seen":"2004-10-25","last_seen":"2004-10-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001263499","retrieved_at":"2026-08-24T10:45:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}